Bibliographie (2546)
Roundup on Covid vaccines | A Big Hit, A Big Miss, & Mixed Vaccine Schedules: The 18-Month Mark.
lundi, 05 juillet 2021 04:35 Écrit par Zouhair SouissiA Big Hit, A Big Miss, & Mixed Vaccine Schedules: The 18-Month Mark – Absolutely Maybe Blog Commentary on Twitter My latest roundup on Covid vax: a big hit, a big miss, & mixed vaccine schedules. 15 vaxes with phase 3 results coming up to the 18-month mark! More than 20 controlled community impact […]
The post Roundup on Covid vaccines | A Big Hit, A Big Miss, & Mixed Vaccine Schedules: The 18-Month Mark. appeared first on Links Medicus.
Why Covid-19 outbreaks in countries using Chinese vaccines don’t necessarily mean the shots have failed.
lundi, 05 juillet 2021 04:35 Écrit par Zouhair SouissiWhy Covid-19 outbreaks in countries using Chinese vaccines don’t necessarily mean the shots have failed – CNN
The post Why Covid-19 outbreaks in countries using Chinese vaccines don’t necessarily mean the shots have failed. appeared first on Links Medicus.
Opinion | Covid is a greater risk to young people than the vaccines.
lundi, 05 juillet 2021 04:35 Écrit par Zouhair SouissiCovid Is a Greater Risk to Young People Than the Vaccines – The New York Times Counterpoint: Weighing myocarditis cases, ACIP failed to balance the harms vs benefits of 2nd doses – by Wesley Pegden AND Vaccine-Induced Myocarditis Concerns Demand Respect, Not Absolutism – Medscape (free registration required) Commentary on Twitter “Realize the choice […]
The post Opinion | Covid is a greater risk to young people than the vaccines. appeared first on Links Medicus.
![[Press release] J&J single-shot COVID-19 vaccine generates strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants.](/media/k2/items/cache/6fabeebf57a31d7fcb8c80ffa6f11c39_M.jpg)
[Press release] J&J single-shot COVID-19 vaccine generates strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants.
vendredi, 02 juillet 2021 15:58 Écrit par Zouhair SouissiPress release: Positive New Data for Johnson & Johnson Single-Shot COVID-19 Vaccine on Activity Against Delta Variant and Long-lasting Durability of Response Commentary: J&J Covid Shot Neutralizes Delta Variant, Company Says – Bloomberg (a few articles per month are free)
The post [Press release] J&J single-shot COVID-19 vaccine generates strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants. appeared first on Links Medicus.
The 3 Simple Rules That Underscore the Danger of Delta – “Vaccines are still beating the variants, but the unvaccinated world is being pummeled”.
vendredi, 02 juillet 2021 15:58 Écrit par Zouhair SouissiThe 3 Simple Rules That Underscore the Danger of Delta – The Atlantic
The post The 3 Simple Rules That Underscore the Danger of Delta – “Vaccines are still beating the variants, but the unvaccinated world is being pummeled”. appeared first on Links Medicus.
Vaccine-induced immune thrombotic thrombocytopenia (VITT) – a novel clinico-pathological entity with heterogeneous clinical presentations.
vendredi, 02 juillet 2021 15:58 Écrit par Zouhair SouissiVaccine-induced immune thrombotic thrombocytopenia (VITT) – a novel clinico-pathological entity with heterogeneous clinical presentations – British Journal of Haematology Commentary: Blood clots related to AstraZeneca/Oxford vaccine can be mitigated with early detection – MedicalXpress
The post Vaccine-induced immune thrombotic thrombocytopenia (VITT) – a novel clinico-pathological entity with heterogeneous clinical presentations. appeared first on Links Medicus.
![[Preprint] Mixing Covid jabs has good immune response, study finds – “The Com-Cov trial looked at the efficacy of either two doses of Pfizer, two of AstraZeneca, or one of them followed by the other. All combinations worked well, priming the immune system](/media/k2/items/cache/b639fbae8945f8d0376a8e5b71d22158_S.jpg)
[Preprint] Mixing Covid jabs has good immune response, study finds – “The Com-Cov trial looked at the efficacy of either two doses of Pfizer, two of AstraZeneca, or one of them followed by the other. All combinations worked well, priming the immune system
vendredi, 02 juillet 2021 15:58 Écrit par Zouhair SouissiMixing Covid jabs has good immune response, study finds – BBC Original study (preprint): Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine – SSRN Preprints with the Lancet
The post [Preprint] Mixing Covid jabs has good immune response, study finds – “The Com-Cov trial looked at the efficacy of either two doses of Pfizer, two of AstraZeneca, or one of them followed by the other. All combinations worked well, priming the immune system”. appeared first on Links Medicus.
Analysis: How long does covid-19 immunity last?
jeudi, 01 juillet 2021 13:20 Écrit par Zouhair SouissiHow long does covid-19 immunity last? – The BMJ
The post Analysis: How long does covid-19 immunity last? appeared first on Links Medicus.
Perspective | Why no one is sure if Delta is deadlier – “The variants are spreading faster, but they don’t necessarily have incentive to kill more often”.
jeudi, 01 juillet 2021 13:20 Écrit par Zouhair SouissiWhy No One Is Sure If Delta Is Deadlier – The Atlantic
The post Perspective | Why no one is sure if Delta is deadlier – “The variants are spreading faster, but they don’t necessarily have incentive to kill more often”. appeared first on Links Medicus.
RCT: Novavax vaccine conferred 89.7% protection against symptomatic SARS-CoV-2 infection and 100% protection against hospitalizations or deaths.
jeudi, 01 juillet 2021 13:20 Écrit par Zouhair SouissiSafety and Efficacy of NVX-CoV2373 Covid-19 Vaccine – New England Journal of Medicine Audio interview: Audio Interview: Another New Covid-19 Vaccine – New England Journal of Medicine Related: Opinion | The mRNA vaccines are extraordinary, but Novavax is even better
The post RCT: Novavax vaccine conferred 89.7% protection against symptomatic SARS-CoV-2 infection and 100% protection against hospitalizations or deaths. appeared first on Links Medicus.
